HOME     |     CONTACT


Search  

EastGen News

SEMEX ANNOUNCES JON SCHEFERS NAMED US GENERAL MANAGER
Semex Is Pleased To Announce The Appointment of Jon Schefers as the US General Manager, Effectiv...
NEOGEN® AND SEMEX® PARTNER TO DELIVER SEMEX’S IMMUNITY TECHNOLOGY FOR HEALTHIER HERDS
Neogen Corporation and Semex announced today their partnership to deliver Semex’s Immunity Te...
SEMEX ANNOUNCES RYAN LETT SUCCEEDS DAVID MAYO AT SEMEX NEW ZEALAND
Semex is pleased to announce that Ryan Lett will succeed David Mayo as General Manager of Semex N...
BOVITEQ ANNOUNCES NEW LAB & SATELLITE AT ARIZONA DAIRY COMPANY
Boviteq is thrilled to announce opening a cutting-edge OPU (Oocyte Pick-Up) satellite facility and ...
SEMEX 2025-2026 BOARD OF DIRECTORS ANNOUNCED
Semex is pleased to announce its 2025-2026 Board of Directors. Jean-François Morin (CIAQ) wi...
BOVITEQ ANNOUNCES NEW LICENSEE IN JAPAN
Boviteq is pleased to announce that Nosawa, a longstanding partner of Semex for over 40 years, will...

View All Articles
Immunity Female Genomics Are Here!
Article posted on October 9, 2018, 10:37:30

Semex is now offering female genomic testing for all commercial traits. Along with every genomic test, clients will also receive Immune genomics estimates for every tested female. Tested females will be classified as having High, Average or Low Immune genomic status. Those animals classified as High will receive the official Semex Immunity Female designation. Female Immune Genomics have been validated in commercial herds in the United States.


How are genomic values calculated?
Single-step methodology (Misztal et al., 2009) is used to combine genotypes and phenotypes of thousands of animals to estimate genomic values for Anti-Body Mediated and Cell-Mediated Immune Response. Applying all animals tested for Immune Response using the University of Guelph's patented High Immune Response test as a reference population, genomic values for any genotyped Holstein animal can be calculated. Immune Response is highly heritable, and so genomic selection with a moderate size reference population is highly accurate. Animals that exceed 1 standard deviation above population mean are classified as High. Animals less than 1 standard deviation beow the population mean are classified as Low.


What is the impact of Immunity Female on farm? 
Fifteen large commercial herds in the United States were analyzed to assess the impact of Female Immune Genomics on disease incidence. Mastitis, lameness and total disease frequency in heifers and cows (any case of routinely recorded disease) were analyzed as the most prevalent and consistently well-recorded traits. Disease frequencies reflect the current population average, including some animals in early lactation. A model was fit to determine the effect of High Immune Genomic females compared to herdmates, after fixed effects for herd, age, and parity. All traits investigated were found to be significant (p<0.05) (Table 1 above). Semex will continue to validate the effect of Immune genomics in commercial herds as more and more animals are genotyped with Elevate® in the coming years, ensuring we are delivering true herd health. 




Print this Article | Email this Article